IRONWOOD PHARMACEUTICALS, INC. Payments for Hedge, Investing Activities
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Payments for Hedge, Investing Activities of $25.20 million for the 1-month period ending 2019-08-31, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForHedgeInvestingActivities · last filed 2023-11-09
- 2019-08-31: Payments for Hedge, Investing Activities 1 month $25.20M.
- 2015-06-30: Payments for Hedge, Investing Activities 1 month $21.10M.
| Period end | Payments for Hedge, Investing Activities 1 month |
|---|---|
| 2019-08-31 | $25.20M 10-Q · filed 2023-11-09 |
| 2015-06-30 | $21.10M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |